DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,716,931 | +31.2% | 164,115 | +26.9% | 1.36% | +33.5% |
| Q2 2023 | $31,036,320 | -58.0% | 129,318 | -55.9% | 1.02% | -61.3% |
| Q1 2023 | $73,890,567 | +49.7% | 293,170 | +57.7% | 2.63% | +39.1% |
| Q4 2022 | $49,357,238 | +13.3% | 185,959 | +10.2% | 1.89% | +9.5% |
| Q3 2022 | $43,567,000 | +5.0% | 168,675 | +3.0% | 1.72% | +9.2% |
| Q2 2022 | $41,504,000 | -13.0% | 163,711 | +0.6% | 1.58% | -4.2% |
| Q1 2022 | $47,725,000 | -45.2% | 162,700 | -38.5% | 1.65% | -40.1% |
| Q4 2021 | $87,073,000 | +9.8% | 264,653 | +1.6% | 2.75% | -5.2% |
| Q3 2021 | $79,330,000 | +13.4% | 260,577 | 0.0% | 2.90% | +10.6% |
| Q2 2021 | $69,928,000 | +21.0% | 260,577 | +1.5% | 2.63% | +9.2% |
| Q1 2021 | $57,808,000 | +42.5% | 256,832 | +40.7% | 2.41% | +32.9% |
| Q4 2020 | $40,563,000 | -28.4% | 182,601 | -30.6% | 1.81% | -43.5% |
| Q3 2020 | $56,679,000 | +1.8% | 263,220 | -16.4% | 3.20% | -9.0% |
| Q2 2020 | $55,655,000 | +27.8% | 314,740 | 0.0% | 3.52% | +5.6% |
| Q1 2020 | $43,563,000 | -13.7% | 314,740 | -4.2% | 3.33% | +7.7% |
| Q4 2019 | $50,450,000 | +36.1% | 328,709 | +28.1% | 3.10% | +153.1% |
| Q3 2019 | $37,065,000 | +1.1% | 256,632 | 0.0% | 1.22% | -1.0% |
| Q2 2019 | $36,678,000 | +7.3% | 256,632 | -0.9% | 1.24% | +3.9% |
| Q1 2019 | $34,179,000 | +1619.3% | 258,892 | +1242.9% | 1.19% | +1424.4% |
| Q4 2018 | $1,988,000 | -5.1% | 19,279 | 0.0% | 0.08% | +9.9% |
| Q3 2018 | $2,095,000 | +10.1% | 19,279 | 0.0% | 0.07% | 0.0% |
| Q2 2018 | $1,902,000 | +0.7% | 19,279 | 0.0% | 0.07% | -17.4% |
| Q1 2018 | $1,888,000 | +5.5% | 19,279 | 0.0% | 0.09% | +4.9% |
| Q4 2017 | $1,789,000 | +8.2% | 19,279 | 0.0% | 0.08% | +2.5% |
| Q3 2017 | $1,654,000 | +33.5% | 19,279 | +31.3% | 0.08% | +27.0% |
| Q2 2017 | $1,239,000 | -1.4% | 14,682 | 0.0% | 0.06% | -1.6% |
| Q1 2017 | $1,256,000 | +9.9% | 14,682 | 0.0% | 0.06% | +3.2% |
| Q4 2016 | $1,143,000 | +465.8% | 14,682 | +468.6% | 0.06% | +313.3% |
| Q3 2016 | $202,000 | -100.0% | 2,582 | -98.3% | 0.02% | -98.9% |
| Q1 2014 | $11,603,000,000 | +13.6% | 154,700 | +17.0% | 1.40% | +7.6% |
| Q4 2013 | $10,210,000,000 | +11.4% | 132,250 | 0.0% | 1.31% | -2.1% |
| Q3 2013 | $9,168,000,000 | +9.5% | 132,250 | 0.0% | 1.33% | +0.3% |
| Q2 2013 | $8,371,000,000 | – | 132,250 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |